Curious to see your top suppliers emissions?
Book a demo for a pilot project
Legend Biotech
Pharmaceutical Preparation ManufacturingUnited StatesNASDAQ: LEGN
Last verified 1 month agolegendbiotech.com
Legend Biotech Corporation, a prominent player in the pharmaceutical preparation manufacturing industry, is headquartered in the United States. Founded in 2014, the company has rapidly established itself as a leader in the development of innovative cell therapies, particularly in the field of oncology.
With a focus on CAR-T cell therapies, Legend Biotech's flagship product, cilta-cel, has garnered significant attention for its unique approach to treating multiple myeloma. The company operates primarily in the US and has expanded its reach into key international markets, enhancing its global footprint.
Recognised for its commitment to advancing healthcare, Legend Biotech has achieved notable milestones, including strategic partnerships and successful clinical trials, solidifying its position as a trailblazer in the biopharmaceutical landscape.
63
DitchCarbon score
+23 vs industry average
Legend Biotech’s score of 63 is higher than 70% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Legend Biotech?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Very Low
Pharmaceutical Preparation Manufacturing is among the least carbon-intensive industries
Industry performance
0.243
02025
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
Emissions trajectory 2020 – 2027
20202021202220232024202520262027
Reported emissions
Scope 1
•••kg CO₂e
Scope 2
•••kg CO₂e
Scope 3
•••kg CO₂e
Total reported
•••kg CO₂e
Scope 3 accounts for ••• of total emissions.
Legend Biotech's reported carbon emissions
Legend Biotech, a US-based pharmaceutical manufacturer, reported its Scope 1 and 2 emissions for 2024. The company's total market-based Scope 1 and 2 emissions were approximately 12.7 million kg CO2e. This comprised about 769,000 kg CO2e from Scope 1 emissions and approximately 11.9 million kg CO2e from market-based Scope 2 emissions. For 2023, Legend Biotech reported total market-based Scope 1 and 2 emissions of about 13.0 million kg CO2e, with Scope 1 emissions at approximately 770,000 kg CO2e and market-based Scope 2 emissions at roughly 12.2 million kg CO2e. The company has not disclosed Scope 3 emissions data. Legend Biotech's climate commitments and initiatives are cascaded from its parent company, Genscript Biotech Corporation.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Legend Biotech’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Legend Biotech yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives
Science Based Targets Initiative
Inherited from Genscript Biotech CorporationSee details
Active
Carbon Disclosure Project
Sign in to view
Active
The Climate Pledge
See details
Not active
UN Global Compact Climate Champions initiative
Inherited from Genscript Biotech CorporationSee details
Not active
RE 100
See details
Not active
Climate Action 100
See details
Not active
Emissions comparison with industry peers
View similar organisationsCompanyCountryIndustryLast updatedScoreDetails
Legend Biotech1 month ago
63
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more